Cardiovascular Risk Assessment in Primary Prevention (Contemporary Cardiology) 1st ed. 2022 Edition
Cardiovascular Risk Assessment in Primary Prevention by Michael D. Shapiro (Editor)
- 发布者 : Humana; 1st ed. 2022 edition (May 27, 2022)
- 语言 : 英语
- 格式:原版 pdf/打印副本
- ISBN-10 : 3030988236
- ISBN-13 : 978-3030988234
原价为:166.47 欧元。€13.02当前价格为:13.02 欧元。
This book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. It provides an overview of current evidence regarding approaches to risk assessment, traditional and emerging risk factors, and atherosclerosis imaging for refinement of risk estimation. The volume seeks to provide an essential resource for professionals in the field to assess their patients for risk of cardiovascular disease.
The book is divided into five sections, starting off with an overview of current best practices to risk assessment in primary prevention around the world. The second section discusses traditional risk factors, such as hypercholesterolemia, hypertension, diabetes, smoking, and obesity. The third section reviews the newly introduced concept of ‘Risk Enhancers’. The fourth section offers insight on novel risk factors, with in-depth discussion regarding lipoprotein(a), high-sensitivity CRP, apolipoprotein B, social determinants of health, stress and cardiovascular disease. and polygenic risk scores. The final section covers the use of non-invasive atherosclerosis imaging (computed tomography and ultrasound-based techniques) as a tool to refine risk estimates. Throughout the book, readers will find multiple tables, figures, and illustrations that complement the text.
Up-to-date, evidence-based, and clinically oriented, Cardiovascular Risk Assessment in Primary Prevention is a must-have resource for physicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention.
社论评论
从封底看
This book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. It provides an overview of current evidence regarding approaches to risk assessment, traditional and emerging risk factors, and atherosclerosis imaging for refinement of risk estimation. The volume seeks to provide an essential resource for professionals in the field to assess their patients for risk of cardiovascular disease. The book is divided into five sections, starting off with an overview of current best practices to risk assessment in primary prevention around the world. The second section discusses traditional risk factors, such as hypercholesterolemia, hypertension, diabetes, smoking, and obesity. The third section reviews the newly introduced concept of ‘Risk Enhancers’. The fourth section offers insight on novel risk factors, with in-depth discussion regarding lipoprotein(a), high-sensitivity CRP, apolipoprotein B, social determinants of health, stress and cardiovascular disease. and polygenic risk scores. The final section covers the use of non-invasive atherosclerosis imaging (computed tomography and ultrasound-based techniques) as a tool to refine risk estimates. Throughout the book, readers will find multiple tables, figures, and illustrations that complement the text.
Up-to-date, evidence-based, and clinically oriented, Cardiovascular Risk Assessment in Primary Prevention is a must-have resource for physicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention.
关于作者
迈克尔夏皮罗 is the inaugural Fred M. Parrish Professor of Cardiology and Molecular Medicine at Wake Forest University where he is on faculty in the Section of Cardiovascular Medicine. After completing a cardiology fellowship, Michael spent two additional years in a clinical and research fellowship focused on advanced cardiovascular imaging at Massachusetts General Hospital/Harvard Medical School. After training, he was on faculty in the Knight Cardiovascular Institute at Oregon Health & Science University. He served as Director of Atherosclerosis Imaging and Associate Director of the Center for Preventive Cardiology. In 2019, he transitioned to Wake Forest University where he serves as the Director of the Center for Prevention of Cardiovascular Disease and the Co-Director of the NIH T32 Cardiovascular Disease Epidemiology and Prevention Research Fellowship Program.
Michael’s clinical interests revolve around genetic and acquired disorders of cholesterol and triglycerides, atherosclerosis imaging, genetic predisposition to early myocardial infarction, and cardiovascular risk assessment. Michael has published extensively in the areas of atherosclerosis imaging, lipid disorders, and preventive cardiology. The scope of his research spans translational science, cardiovascular epidemiology, and clinical trials of novel lipid modulating therapeutics. He also serves as a principal investigator on numerous clinical trials testing novel lipid modulating therapeutics.
关于我们 PDF 格式(一般) 查看更多
相关信息
显示1-12的451个结果
-
促销!
初级保健高级健康评估和临床诊断第六版
原价为:49.29 欧元。€7.44当前价格为:7.44 欧元。 -
促销!
纳达斯《小儿心脏病学》第三版
原价为:120.90 欧元。€15.81当前价格为:15.81 欧元。 -
促销!
伯恩斯儿科初级保健第 8 版
原价为:92.99 欧元。€20.46当前价格为:20.46 欧元。 -
促销!
家庭实践指南第六版
原价为:65.10 欧元。€13.02当前价格为:13.02 欧元。 -
促销!
循证从业者应用研究满足客户需求第二版
原价为:55.80 欧元。€9.30当前价格为:9.30 欧元。 -
促销!
血管和血管内外科专家外科实践的伴侣第七版
原价为:55.80 欧元。€9.30当前价格为:9.30 欧元。 -
促销!
临床伦理学 临床医学伦理决策的实用方法,第九版 第 9 版
原价为:130.20 欧元。€16.74当前价格为:16.74 欧元。 -
促销!
2024 年初级保健现行实践指南,第 21 版
原价为:83.70 欧元。€15.81当前价格为:15.81 欧元。 -
心脏麻醉和经食管超声心动图(兰格医学书)
€9.30 -
促销!
初级保健:跨专业协作实践第七版
原价为:83.70 欧元。€14.88当前价格为:14.88 欧元。 -
促销!
前列腺动脉栓塞第一版。 1年版
原价为:65.10 欧元。€8.37当前价格为:8.37 欧元。 -
促销!
先天性心脏病的麻醉第四版 (EPUB)
原价为:55.80 欧元。€6.51当前价格为:6.51 欧元。